Gene expression profiling of peri-implant healing of PLGA-Li+ implants suggests an activated Wnt signaling pathway in vivo

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Thorfve, Anna ^a,b   Bergstrand, Anna ^c,d   Ekström, Karin ^a,b   Lindahl, Anders ^a,b   Thomsen, Peter ^a,b   Larsson, Anette ^c,d   Tengvall, Pentti ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy   (Sweden)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^d SuMo BIOMATERIALS VINN Excellence Center   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCITONIN RECEPTOR; LITHIUM ION; POLYGLACTIN; TRANSCRIPTION FACTOR RUNX2; LACTIC ACID; LITHIUM; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPORIN GENE; BONE GROWTH; BONE REGENERATION; CHONDROGENESIS; CLUSTER ANALYSIS; CONTROLLED STUDY; FOS LIKE ANTIGEN 1 GENE; GENE EXPRESSION PROFILING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMPLANT; IN VIVO STUDY; INFLAMMATION; MALE; MICROARRAY ANALYSIS; MORPHOMETRICS; NONHUMAN; POLYMERASE CHAIN REACTION; RAT; TIBIA; WNT SIGNALING PATHWAY; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PROSTHESES AND ORTHOSES; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; SURGERY; ULTRASTRUCTURE;

ANIMALS; BONE REGENERATION; GENE EXPRESSION PROFILING; LACTIC ACID; LITHIUM; MALE; POLYGLYCOLIC ACID; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIBIA; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84904576603     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102597     Document Type: Article

References (71)

1. Bonucci EE (2011) Bone mineralization. Front Biosci (Elite Ed) 17: 100-128.
2. Komori T (2009) Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 339: 189-195. doi:10.1007/s00441-009- 0832-8.
3. Kim JH, Liu X, Wang J, Chen X, Zhang H, et al. (2013) Wnt signaling in bone formation and its therapeutic potential for bone diseases. Ther Adv Musculoskelet Dis 5: 13-31. doi:10.1177/1759720X12466608.
4. Heilmann A, Schinke T, Bindl R, Wehner T, Rapp A, et al. (2013) The Wnt Serpentine Receptor Frizzled-9 Regulates New Bone Formation in Fracture Healing. PLoS ONE 8: e84232. doi:10.1371/journal.pone.0084232.g007.
5. Albers J, Schulze J, Beil FT, Gebauer M, Baranowsky A, et al. (2011) Control of bone formation by the serpentine receptor Frizzled-9. The Journal of Cell Biology 192: 1057-1072. doi:10.1073/pnas.0504754102.
6. Olivares-Navarrete R, Hyzy SL, Park JH, Dunn GR, Haithcock DA, et al. (2011) Mediation of osteogenic differentiation of human mesenchymal stem cells on titanium surfaces by a Wnt-integrin feedback loop. Biomaterials 32: 6399-6411. doi:10.1016/j.biomaterials.2011.05.036.
7. Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209. doi:10.1172/JCI28551.
8. Lories RJ, Corr M, Lane NE (2013) To Wnt or not to Wnt: the bone and joint health dilemma. Nature Publishing Group 9: 328-339. doi:10.1038/nrrheum. 2013.25.
9. Monroe DG, McGee-Lawrence ME, Oursler MJ, Westendorf JJ (2012) Update on Wnt signaling in bone cell biology and bone disease. Gene 492: 1-18. doi:10.1016/j.gene.2011.10.044.
10. Clevers H, Nusse R (2012) Wnt/b-Catenin Signaling and Disease. Cell 149: 1192-1205. doi:10.1016/j.cell.2012.05.012.
11. Malhi GS, Tanious M, Das P, Berk M (2012) The science and practice of lithium therapy. Australian and New Zealand Journal of Psychiatry 46: 192-211. doi:10.1177/0004867412437346.
12. Gould TD, Manji HK (2002) The Wnt Signaling Pathway in Bipolar Disorder. The Neuroscientist 8: 497-511. doi:10.1177/107385802237176.
13. Clement-Lacroix P, Ai M, Morvan F, Roman-Roman S, Vayssiere B, et al. (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA 102: 17406-17411. doi:10.1073/pnas.0505259102. (Pubitemid 41740879)
14. Vestergaard P, Rejnmark L, Mosekilde L (2005) Reduced Relative Risk of Fractures Among Users of Lithium. Calcif Tissue Int 77: 1-8. doi:10.1007/s00223-004-0258-y. (Pubitemid 41504166)
15. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, et al. (2012) PLGA-based nanoparticles: An overview of biomedical applications. Journal of Controlled Release 161: 505-522. doi:10.1016/j.jconrel.2012.01.043.
16. Lanao RPF, Jonker AM, Wolke JGC, Jansen JA, van Hest JCM, et al. (2013) Physicochemical Properties and Applications of Poly(lactic-co-glycolic acid) for Use in Bone Regeneration. Tissue Eng Part B Rev 19: 380-390. doi:10.1089/ten.teb.2012.0443.
17. Meyer F, Wardale J, Best S, Cameron R, Rushton N, et al. (2011) Effects of lactic acid and glycolic acid on human osteoblasts: A way to understand PLGA involvement in PLGA/calcium phosphate composite failure. J Orthop Res 30: 864-871. doi:10.1002/jor.22019.
18. Khang G, Lee SJ, Kim MS, Lee HIB (2006) Biomaterials: Tissue Engineering and Scaffolds. Encyclopedia of Medical Devices and Instrumentation: 366-383.
19. Wang F, Song Y-L, Li C-X, Li D-H, Zhang H-P, et al. (2010) Sustained release of insulin-like growth factor-1 from poly(lactide-co-glycolide) microspheres improves osseointegration of dental implants in type 2 diabetic rats. European Journal of Pharmacology 640: 226-232. doi:10.1016/j.ejphar.2010. 04.024.
20. Dreifke MB, Ebraheim NA, Jayasuriya AC (2013) Investigation of potential injectable polymeric biomaterials for bone regeneration. J Biomed Mater Res 101A: 2436-2447. doi:10.1002/jbm.a.34521.
21. Félix Lanao RP, Bosco R, Leeuwenburgh SCG, Kersten-Niessen MJF, Wolke JGC, et al. (2013) RANKL delivery from calcium phosphate containing PLGA microspheres. J Biomed Mater Res 101: 3123-3130. doi:10.1002/jbm.a.34623.
22. Son JS, Choi Y-A, Park E-K, Kwon T-Y, Kim K-H, et al. (2012) Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers. J Biomed Mater Res 101B: 247-257. doi:10.1002/jbm.b.32834.
23. Tiainen J, Soini Y, T rm l P, Waris T, Ashammakhi N (2004) Self-reinforced polylactide/polyglycolide 80/20 screws take more than 1 1/2 years to resorb in rabbit cranial bone. J Biomed Mater Res 70B: 49-55. doi:10.1002/jbm.b.30013. (Pubitemid 38849989)
24. Han P, Wu C, Chang J, Xiao Y (2012) The cementogenic differentiation of periodontal ligament cells via the activation of Wnt/β-catenin signalling pathway by Li+ ions released from bioactive scaffolds. Biomaterials 33: 6370-6379. doi:10.1016/j.biomaterials.2012.05.061.
25. Wang J, de Groot K, van Blitterswijk C, de Boer J (2009) Electrolytic deposition of lithium into calcium phosphate coatings. Dental Materials 25: 353-359. doi:10.1016/j.dental.2008.07.013.
26. Galli C, Piemontese M, Lumetti S, Manfredi E, Macaluso GM, et al. (2013) GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. Clinical Oral Implants Research 24: 921-927. doi:10.1111/j.1600-0501.2012.02488.x.
27. de Boer J, Siddappa R, Gaspar C, van Apeldoorn A, Fodde R, et al. (2004) Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34: 818-826. doi:10.1016/j.bone.2004.01.016. (Pubitemid 38581127)
28. Thalji G, Gretzer C, Cooper LF (2013) Comparative molecular assessment of early osseointegration in implant-adherent cells. Bone 52: 444-453. doi:10.1016/j.bone.2012.07.026.
29. Wise JK, Sena K, Vranizan K, Pollock JF, Healy KE, et al. (2010) Temporal gene expression profiling during rat femoral marrow ablation-induced intramembranous bone regeneration. PLoS ONE 5. doi:10.1371/journal.pone.0012987.
30. Ivanovski S, Hamlet S, Salvi GE, Huynh-Ba G, Bosshardt DD, et al. (2011) Transcriptional profiling of osseointegration in humans. Clinical Oral Implants Research 22: 373-381. doi:10.1111/j.1600-0501.2010.02112.x.
31. Donos N, Hamlet S, Lang NP, Salvi GE, Huynh-Ba G, et al. (2011) Gene expression profile of osseointegration of a hydrophilic compared with a hydrophobic microrough implant surface. Clinical Oral Implants Research 22: 365-372. doi:10.1111/j.1600-0501.2010.02113.x.
32. Kojima N, Ozawa S, Miyata Y, Hasegawa H, Tanaka Y, et al. (2008) High-throughput gene expression analysis in bone healing around titanium implants by DNA microarray. Clinical Oral Implants Research 19: 173-181. doi:10.1111/j.1600-0501.2007.01432.x.
33. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264. doi:10.1093/biostatistics/4. 2.249.
34. Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 37: 1-13.
35. Jiao XX, Sherman BTB, Da Wei da W Huang, Stephens RR, Baseler MWM, et al. (2012) DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics 28: 1805-1806. doi:10.1093/bioinformatics/bts251.
36. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research 30: 207-210. (Pubitemid 34679544)
37. Livak KJ, Schmittgen TD (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-ΔΔCT Method. Methods 25: 402-408. doi:10.1006/meth.2001.1262. (Pubitemid 34164012)
38. Burkersroda von F, Schedl L, Göpferich A (2002) Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials 23: 4221-4231.
39. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273. doi:10.1038/ng1180. (Pubitemid 36792858)
40. Takeda S (2008) Central Control of Bone Remodelling. Journal of Neuroendocrinology 20: 802-807. doi:10.1111/j.1365-2826.2008.01732.x.
41. Gimble JM, Nuttall ME (2012) The relationship between adipose tissue and bone metabolism. Clinical Biochemistry 45: 874-879. doi:10.1016/j.clinbiochem. 2012.03.006.
42. Willert K, Nusse R (1998) Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8: 95-102. (Pubitemid 28122147)
43. Valenta T, Hausmann G, Basler K (2012) The many faces and functions of β-catenin. EMBO J 31: 2714-2736. doi:10.1038/emboj.2012.150.
44. Mu J, Pang Q, Guo Y-H, Chen J-G, Zeng W, et al. (2013) Functional Implications of MicroRNA-215 in TGF-b1-Induced Phenotypic Transition of Mesangial Cells by Targeting CTNNBIP1. PLoS ONE 8: e58622. doi:10.1371/journal. pone.0058622.g007.
45. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, et al. (1999) Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96: 1603-1608. (Pubitemid 29098498)
46. Eferl R, Hoebertz A, Schilling AF, Rath M, Karreth F, et al. (2004) The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J 23: 2789-2799. doi:10.1038/sj.emboj.7600282. (Pubitemid 39013551)
47. Bakiri L, Takada Y, Radolf M, Eferl R, Yaniv M, et al. (2007) Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation. Bone 40: 867-875. doi:10.1016/j.bone.2006.11.005. (Pubitemid 46386538)
48. Heo JS, Lee S-Y, Jeong-Chae Lee (2010) Wnt/b-Catenin Signaling Enhances Osteoblastogenic Differentiation from Human Periodontal Ligament Fibroblasts. Mol Cells 30: 449-454. doi:10.1007/s10059-010-0139-3.
49. Thorfve A, Dehne T, Lindahl A, Brittberg M, Pruss A, et al. (2012) Characteristic Markers of the WNT Signaling Pathways Are Differentially Expressed in Osteoarthritic Cartilage. Cartilage 3: 43-57. doi:10.1177/ 1947603511414178.
50. Ikegawa S (2008) Expression, regulation and function of asporin, a susceptibility gene in common bone and joint diseases. Curr Med Chem 15: 724-728.
51. Kalamajski S, Aspberg A, Lindblom K, Heinegård D, Oldberg Å (2009) Asporin competes with decorin for collagen binding, binds calcium and promotes osteoblast collagen mineralization. Biochem J 423: 53-59. doi:10.1002/jcb.240410404.
52. Miclea RL, Siebelt M, Finos L, Goeman JJ, Löwik CWGM, et al. (2011) Inhibition of Gsk3b in cartilage induces osteoarthritic features through activation of the canonical Wnt signaling pathway. Osteoarthritis and Cartilage 19: 1363-1372. doi:10.1016/j.joca.2011.07.014.
53. Corr M (2008) Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis. Nat Clin Pract Rheumatol 4: 550-556. doi:10.1038/ncprheum0904.
54. Semënov M, Tamai K, He X (2005) SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 280: 26770-26775. doi:10.1074/jbc. M504308200.
55. van Bezooijen RLR, Roelen BAJB, Visser AA, van der Wee-Pals LL, de Wilt EE, et al. (2004) Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199: 805-814. doi:10.1084/jem.20031454.
56. Devarajan-Ketha H, Craig TA, Madden BJ, Robert Bergen H III, Kumar R (2012) The sclerostin-bone protein interactome. Biochemical and Biophysical Research Communications 417: 830-835. doi:10.1016/j.bbrc.2011.12.048.
57. Yoon SJ, Kim SH, Ha HJ, Ko YK, So JW, et al. (2008) Reduction of Inflammatory Reaction of Poly(D,L-Lactic-C o-Glycolic Acid) Using Demineralized Bone Particles. Tissue Eng Part A 14: 539-547. doi:10.1089/tea.2007.0129. (Pubitemid 351520462)
58. Taylor MS, Daniels AU, Andriano KP, Heller J (1994) Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. Journal of Applied Biomaterials 5: 151-157.
59. Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Seminars in Immunology 20: 86-100. doi:10.1016/j.smim.2007.11.004.
60. Zupan J, Jeras M, Marc J (2013) Osteoimmunology and the influence of proinflammatory cytokines on osteoclasts. Biochem Med: 43-63. doi:10.11613/BM.2013.007.
61. Merle B, Garnero P (2012) The multiple facets of periostin in bone metabolism. Osteoporos Int 23: 1199-1212. doi:10.1007/s00198-011-1892-7.
62. Rauner M, Sipos W, Pietschmann P (2007) Osteoimmunology. Int Arch Allergy Immunol 143: 31-48. doi:10.1159/000098223. (Pubitemid 46625234)
63. Ertugrul AS, Sahin H, Dikilitas A, Alpaslan N, Bozoglan A (2013) Evaluation of beta-2 microglobulin and alpha-2 macroglobulin levels in patients with different periodontal diseases. Aust Dent J 58: 170-175. doi:10.1111/adj.12022.
64. Amin Kerachian M, Cournoyer D, Harvey EJ, Chow TY, Bégin LR, et al. (2010) New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model. Arthritis Res Ther 12: R124. doi:10.1186/ar3062.
65. Battiston KG, Labow RS, Santerre JP (2012) Protein binding mediation of biomaterial-dependent monocyte activation on a degradable polar hydrophobic ionic polyurethane. Biomaterials 33: 8316-8328. doi:10.1016/j.biomaterials.2012. 08.014.
66. Anderson JMJ, Defife KK, McNally AA, Collier TT, Jenney CC (1999) Monocyte, macrophage and foreign body giant cell interactions with molecularly engineered surfaces. J Mater Sci: Mater Med 10: 579-588.
67. Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, et al. (2006) Monocyte Chemotactic Protein-3 Is a Myocardial Mesenchymal Stem Cell Homing Factor. Stem Cells 25: 245-251. doi:10.1634/stemcells.2006-0293.
68. Shinohara K, Greenfield S, Pan H, Vasanji A, Kumagai K, et al. (2011) Stromal cell-derived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair. J Orthop Res 29: 1064-1069. doi:10.1002/jor.21374.
69. Chen L, Tredget EE, Wu PYG, Wu Y (2008) Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing. PLoS ONE 3: e1886. doi:10.1371/journal.pone.0001886.t003.
70. De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, et al. (2013) Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121: 4930-4937. doi:10.1182/blood-2013-02-486217.
71. Alblowi J, Tian C, Siqueira MF, Kayal RA, McKenzie E, et al. (2013) Chemokine expression is upregulated in chondrocytes in diabetic fracture healing. Bone 53: 294-300. doi:10.1016/j.bone.2012.12.006.